Although molecular bases of many well-known cadherins e.g. CDH1 (E-cadherin) and CDH2 (N-cadherin) in cancer development have been established, we know very little about genetic/functional impacts of other AJ genes on cancer especially cutaneous melanoma, a unique cancer type with a high mutation load. Here, CDH2 is linked to cutaneous melanoma.